Objective: Coronavirus disease 2019 (COVID-19) is a global pandemic involving> 5 500
000 cases worldwide as of May 26, 2020. The culprit is the severe acute respiratory …

Background Obesity is an established risk factor for severe COVID-19 outcomes. The
mechanistic underpinnings of this association are not well-understood. Objective To …

SARS-CoV-2, a novel coronavirus found in Wuhan (China) at the end of 2019, is the
etiological agent of the current pandemic that is a heterogeneous disease, named …

The coronavirus disease of 2019 (COVID-19) pandemic has dominated everyday life around
the globe for almost two years now. While effective COVID-19 vaccines became available …

Background Recent studies have shown that obesity is associated with the severity of
coronavirus disease (COVID-19). We reviewed clinical studies to clarify the obesity …

Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has been led to a pandemic emergency. So far …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …

Severe obesity increases the risk for negative outcomes in patients with coronavirus disease
2019 (COVID-19). Our objectives were to investigate the effect of BMI on in-hospital …

One of the hallmarks of the SARS-CoV-2 infection has been the inflammatory process that
played a role in its pathogenesis, resulting in mortality within susceptible individuals. This …

Background SARS-CoV-2 targets endothelial cells through the angiotensin-converting
enzyme 2 receptor. The resulting endothelial injury induces widespread thrombosis and …